News

Rona Therapeutics Announces NMPA Approval of IND Application for RN1871, a Novel Angiotensinogen (AGT)-Targeting siRNA Drug for Hypertension
Rona Therapeutics, a biotechnology company pioneering innovative RNA-targeted therapies, announced that the Investigational New Drug (IND) application for RN1871, a small interfering RNA (siRNA) drug ...
Yahoo Finance2d
Rona Therapeutics Announces NMPA Approval of IND Application for RN1871, a Novel Angiotensinogen (AGT)-Targeting siRNA Drug for Hypertension
SHANGHAI, April 21, 2025 /PRNewswire/ -- Rona Therapeutics, a biotechnology company pioneering innovative RNA-targeted therapies, announced that the Investigational New Drug (IND) application for ...
Pharmabiz1d
China NMPA approves Rona Therapeutics’ IND application for RN1871, a novel AGT-targeting siRNA drug for hypertension
China NMPA approves Rona Therapeutics’ IND application for RN1871, a novel AGT-targeting siRNA drug for hypertension: Shanghai, China Tuesday, April 22, 2025, 18:00 Hrs [IST] Ro ...
Le Lézard2d
ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio
Evogene Ltd. a leading computational biology company focused on revolutionizing life-science-based product discovery and ...
Le Lézard2d
4M Therapeutics to Present at the Upcoming American Psychological Association and American Society of Clinical Psychopharmacology Annual Meetings
M Therapeutics Inc. (4MTx), an early-stage biotechnology company developing treatments for neuropsychiatric and neurodegenerative diseases, today announced that the Company's CEO, Pablo Lapuerta, M.D.
The Manila Times2d
KOREAN LENDERS AND OCEAN WEST CAPITAL PARTNERS FORECLOSE ON MIDTOWN MANHATTAN OFFICE BUILDING
Ocean West Capital Partners ('Ocean West') led the successful UCC foreclosure of 285 Madison Avenue last week, a 511,000 ...
The Free Press Journal1d
IPL 2025: 'Maine Rona Shuru Kardiya...', Says Musheer Khan As He Receives A Bat From Virat Kohli After PBKS Vs RCB Match; Video
Punjab Kings' young cricketer Musheer Khan experienced a heartwarming moment during the IPL 2025 match against Royal Challengers Bengaluru at the Maharaja Yadavindra Singh International Cricket ...
Nasdaq6d
Tvardi Therapeutics, Inc. Rings the Closing Bell
Tvardi Therapeutics, Inc. (Nasdaq: TVRD), a clinical-stage biopharmaceutical company developing novel STAT3 inhibitors for fibrosis-driven diseases, visits the Nasdaq MarketSite in Times Square.